BioPharmSignal logoBioPharmSignal

Biotech News

Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Immix Biopharma (IMMX)Immix BiopharmaConference / presentation

LOS ANGELES, CA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ("ImmixBio", "Company", "We" or "Us" or "IMMX"), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will participate and host institutional investor meetings at the Morgan Stanley 24th Annual Global Healthcare Conference being held September 14-16, 2026 in New...

Related news

IMMXImmix Biopharma2026-10-05 13:45 EST

Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference

ERASErasca2026-09-08 11:00 EST

Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

LEGNLegend Biotech Corporation2026-09-01 12:00 EST

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

LYELLyell Immunopharma2026-09-14 11:00 EST

Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference

FATEFate Therapeutics2026-09-03 11:00 EST

Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference

MGNXMacroGenics2026-09-09 20:05 EST

MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

REPLReplimune Group2026-09-03 12:00 EST

Replimune to Present at the Cantor Global Healthcare Conference 2026

KURAKura Oncology2026-09-01 11:15 EST

Kura Oncology to Participate in Three Investor Conferences in September

CHRSCoherus BioSciences, Inc.2026-08-31 13:30 EST

Coherus to Participate in Upcoming Investor Conferences

IMMXImmix Biopharma2026-09-30 22:15 EST

Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock

View all latest news

Immix Biopharma

Immix Biopharma is a biotechnology company focused on immune-driven therapies and oncology programs. Its strategy centers on translating immune biology into targeted treatment options.

Recent company news

IMMXImmix Biopharma2026-10-05 13:45 EST

Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference

IMMXImmix Biopharma2026-09-30 22:15 EST

Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock

IMMXImmix Biopharma2026-09-30 22:15 EST

Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock

IMMXImmix Biopharma2026-09-29 12:05 EST

Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock

IMMXImmix Biopharma2026-09-29 12:05 EST

Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock

Stock data

Close
10.23 USD
Market cap
595.5M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States